Literature DB >> 10514161

Science, medicine, and the future. Contraception.

D T Baird1, A F Glasier.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10514161      PMCID: PMC1116802          DOI: 10.1136/bmj.319.7215.969

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  13 in total

1.  Do women want a once-a-month pill?

Authors:  C Rimmer; M Horga; V Cerar; E M Alder; D T Baird; A Glasier
Journal:  Hum Reprod       Date:  1992-05       Impact factor: 6.918

2.  Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.

Authors:  V Beral; C Hermon; C Kay; P Hannaford; S Darby; G Reeves
Journal:  BMJ       Date:  1999-01-09

Review 3.  Progestin-androgen combination regimens for male contraception.

Authors:  M C Meriggiola; W J Bremner
Journal:  J Androl       Date:  1997 May-Jun

4.  A fifth freedom?

Authors:  D Baird
Journal:  Br Med J       Date:  1965-11-13

5.  Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol.

Authors:  M L Swahn; M Bygdeman; J K Chen; K Gemzell-Danielsson; S Song; Q Y Yang; P J Yang; M L Qian; W F Chang
Journal:  Hum Reprod       Date:  1999-02       Impact factor: 6.918

6.  The use of integrins for the assessment of uterine receptivity.

Authors:  B A Lessey
Journal:  Fertil Steril       Date:  1994-05       Impact factor: 7.329

Review 7.  7 alpha-methyl-nortestosterone (MENT): the optimal androgen for male contraception.

Authors:  K Sundaram; N Kumar; C W Bardin
Journal:  Ann Med       Date:  1993-04       Impact factor: 4.709

8.  Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.

Authors:  A Glasier; K J Thong; M Dewar; M Mackie; D T Baird
Journal:  N Engl J Med       Date:  1992-10-08       Impact factor: 91.245

9.  Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.

Authors:  K Gemzell-Danielsson; M L Swahn; P Svalander; M Bygdeman
Journal:  Hum Reprod       Date:  1993-06       Impact factor: 6.918

10.  Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.

Authors:  D P McDonnell; D L Clemm; T Hermann; M E Goldman; J W Pike
Journal:  Mol Endocrinol       Date:  1995-06
View more
  1 in total

1.  Urinary estrogen levels in women on contraceptives in enugu, South-East Nigeria.

Authors:  Ignatius C Maduka; Francis E Ezeonu; Emeka E Neboh; Elvis N Shu; Ebele J Ikekpeazu
Journal:  J Family Med Prim Care       Date:  2012-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.